Open access · CC-BY
via OpenAlex
Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages
Bowen Zheng, Yuying Wang, Baian Zhou, Fengyuan Qian, Diya Liu, Danrong Ye, Xiqian Zhou, Lin Fang
Journal of Advanced Research · 2024 · ▲ 64 citations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Chronic inflammation
Disabled macroautophagy
Cell culture / in vitro
In vitro
Abstract
INTRODUCTION: Urolithin A (UA) is a naturally occurring compound that is converted from ellagitannin-like precursors in pomegranates and nuts by intestinal flora. Previous studies have found that UA exerts tumor-suppressive effects through antitumor cell proliferation and promotion of memory T-cell expansion, but its role in tumor-associated macrophages remains unknown. OBJECTIVES: Our study aims to reveal how UA affects tumor macrophages and tumor cells to inhibit breast cancer progression. METHODS: Observe the effect of UA treatment on breast cancer progression though in vivo and in vitro experiments. Western blot and PCR assays were performed to discover that UA affects tumor macrophage autophagy(definition) and inflammation. Co-ip and Molecular docking were used to explore specific molecular mechanisms. RESULTS: We observed that UA treatment could simultaneously inhibit harmful inflammatory factors, especially for InterleuKin-6 (IL-6) and tumor necrosis factor α (TNF-α), in both breast cancer cells and tumor-associated macrophages, thereby improving the tumor microenvironment and delaying tumor progression. Mechanistically, UA induced the key regulator of autophagy, transcription factor EB (TFEB), into the nucleus in a partially mTOR(definition)-dependent manner and inhibited the ubiquitination degradation of TFEB, which facilitated the clearance of damaged mitochondria via the mitophagy-lysosomal pathway in macrophages under tumor supernatant stress, and reduced the deleterious inflammatory factors induced by the release of nucleic acid from damaged mitochondria. Molecular docking and experimental studies suggest that UA block the recognition of TFEB by 1433 and induce TFEB nuclear localization. Notably, UA treatment demonstrated inhibitory effects on tumor progression in multiple breast cancer models. CONCLUSION: Our study elucidated the anti-breast cancer effect of UA from the perspective of tumor-associated macrophages. Specifically, TFEB is a crucial downstream target in macrophages.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jare.2024.04.010
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Zheng, B., Wang, Y., Zhou, B., Qian, F., Liu, D., Ye, D., Zhou, X., & Fang, L. (2024). Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages. <em>Journal of Advanced Research</em>. https://doi.org/10.1016/j.jare.2024.04.010
Vancouver
Zheng B, Wang Y, Zhou B, Qian F, Liu D, Ye D, et al. Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages. Journal of Advanced Research. 2024. doi:10.1016/j.jare.2024.04.010.
BibTeX
@article{bowen2024Urolit,
title = {Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages},
author = {Bowen Zheng and Yuying Wang and Baian Zhou and Fengyuan Qian and Diya Liu and Danrong Ye and Xiqian Zhou and Lin Fang},
journal = {Journal of Advanced Research},
year = {2024},
doi = {10.1016/j.jare.2024.04.010},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Cycle 2010
Open access · OA
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis
Frontiers in Nutrition 2025
Open access · CC-BY
Polyphenols and exercise in autophagy regulation: potential benefits for cancer management and healthspan
International Journal of Biological Sciences 2024
Open access · CC-BY
Targeting mitochondria by lipid-selenium conjugate drug results in malate/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression
Cancer Prevention Research 2011
Open access · OA
Role of Autophagy in Cancer Prevention
Cancers 2019
Open access · CC-BY
EMT and Stemness—Key Players in Pancreatic Cancer Stem Cells
Experimental Physiology 2011
Citation only